Quiz: Multiple Myeloma Incidence in 2017

Article

How many people this year are expected to be diagnosed with multiple myeloma in the United States? And how does the rate of incidence differ between black patients and white patients, or between men and women? Test your knowledge on multiple myeloma in our latest quiz.

How many people this year are expected to be diagnosed with multiple myeloma in the United States? And how does the rate of incidence differ between black patients and white patients, or between men and women? Test your knowledge on multiple myeloma in our latest quiz.

Question 1

Answer and Question 2 on Next Page »

Answer

B.False

Multiple myeloma is more common in men than in women.

Question 2

Answer and Question 3 on Next Page »

Answer

D. 30,280

This year, according to the American Cancer Society, it is estimated that 17,490 men and 12,790 women will be diagnosed with multiple myeloma.

Question 3

Answer and Question 4 on Next Page »

Answer

C. 12,590

This year it is estimated that 6,660 men and 5,930 women with multiple myeloma will die from their disease, according to the American Cancer Society.

Question 4

Answer on Next Page »

Answer

A. True

According to one study, 14.8 black men and 10.5 black women per every 100,000 are diagnosed with multiple myeloma in the United States compared with 7.2 white men and 4.3 white women per every 100,000.

 

Recent Videos
Marc S. Raab, MD, PhD, details how agents like carfilzomib may play a role in treatment after progression on teclistamab-based induction therapy.
The safety profile of teclistamab-based therapy in the MajesTEC-5 trial was expected based on the known compounds employed in each combination.
“Every patient [with multiple myeloma] should be offered CAR T before they’re offered a bispecific, with some rare exceptions,” said Barry Paul, MD.
Barry Paul, MD, listed cilta-cel, anito-cel, and arlo-cel as 3 of the CAR T-cell therapies with the most promising efficacy in patients with multiple myeloma.
Related Content